SI1296689T1 - Nacin dajanja pacientu bisfosfonatov - Google Patents

Nacin dajanja pacientu bisfosfonatov

Info

Publication number
SI1296689T1
SI1296689T1 SI200130459T SI200130459T SI1296689T1 SI 1296689 T1 SI1296689 T1 SI 1296689T1 SI 200130459 T SI200130459 T SI 200130459T SI 200130459 T SI200130459 T SI 200130459T SI 1296689 T1 SI1296689 T1 SI 1296689T1
Authority
SI
Slovenia
Prior art keywords
administering bisphosphonates
bisphosphonates
administering
Prior art date
Application number
SI200130459T
Other languages
English (en)
Inventor
Zebulun D Horowitz
Peter C Richardson
Ulrich Trechsel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32595500&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1296689(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from EP01940580A external-priority patent/EP1296689B3/en
Publication of SI1296689T1 publication Critical patent/SI1296689T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
SI200130459T 2000-06-20 2001-06-18 Nacin dajanja pacientu bisfosfonatov SI1296689T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US59713500A 2000-06-20 2000-06-20
US26768901P 2001-02-09 2001-02-09
EP01940580A EP1296689B3 (en) 2000-06-20 2001-06-18 Method of administering bisphosphonates
PCT/EP2001/006850 WO2001097788A2 (en) 2000-06-20 2001-06-18 Method of administering bisphosphonates

Publications (1)

Publication Number Publication Date
SI1296689T1 true SI1296689T1 (sl) 2006-08-31

Family

ID=32595500

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200131018T SI1591122T1 (sl) 2000-06-20 2001-06-18 Postopek za aplikacijo bisfosfonatov
SI200130459T SI1296689T1 (sl) 2000-06-20 2001-06-18 Nacin dajanja pacientu bisfosfonatov

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200131018T SI1591122T1 (sl) 2000-06-20 2001-06-18 Postopek za aplikacijo bisfosfonatov

Country Status (6)

Country Link
EP (1) EP1591122B1 (sl)
DK (1) DK1591122T3 (sl)
LU (1) LU92174I2 (sl)
RU (1) RU2288722C2 (sl)
SI (2) SI1591122T1 (sl)
ZA (1) ZA200210361B (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102597149A (zh) * 2009-07-21 2012-07-18 迈兰公司 用于连续制造聚异丁烯基透皮贴剂的工艺
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
PT2459176T (pt) 2009-07-31 2017-12-11 Gruenenthal Gmbh Método de cristalização e biodisponibilidade
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
WO2017208070A1 (en) 2016-05-31 2017-12-07 Grünenthal GmbH Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275821B1 (de) 1986-11-21 1992-02-26 Ciba-Geigy Ag Neue substituierte Alkandiphosphonsäuren
GB9408775D0 (en) 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US6015801A (en) * 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
SE9703691D0 (sv) * 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
IT1296495B1 (it) * 1997-11-21 1999-06-25 Prodotti Antibiotici Spa Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare
SK16682001A3 (sk) * 1999-05-21 2002-04-04 Novartis Ag Liečivo na liečenie angiogenézy

Also Published As

Publication number Publication date
EP1591122A1 (en) 2005-11-02
RU2288722C2 (ru) 2006-12-10
DK1591122T3 (da) 2013-02-25
EP1591122B1 (en) 2012-09-26
SI1591122T1 (sl) 2013-02-28
ZA200210361B (en) 2003-11-13
LU92174I2 (fr) 2013-05-22

Similar Documents

Publication Publication Date Title
HUP0301164A3 (en) Method of administering bisphosphonates
HK1052183A1 (zh) 製造tetrahydrobenzothiepines的方法
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
PL363507A1 (en) Pharmaceutical uses of bisphosphonates
GB0023983D0 (en) Therapeutic compounds
GB0008710D0 (en) Therapeutic compounds
HUP0302677A3 (en) A method of alleviation the pain
GB0016681D0 (en) Therapeutic compounds
AU6128301A (en) Method of administering a bisphosphonate
EP1242200A4 (en) METHOD FOR PRODUCING "T" COUPLINGS
GB2366639B (en) Method of comparing parts
SI1591122T1 (sl) Postopek za aplikacijo bisfosfonatov
EP1188441A4 (en) ORAL PREPARATIONS OF DINATRIUM ETIDRONATE
AU5881001A (en) Method of stabilizing preparation
GB0008921D0 (en) Method of treatment
EP1267911A4 (en) TREATMENT METHOD
IL138013A0 (en) Method of safe infusion
GB0024938D0 (en) Method of diagnosis
EP1303281A4 (en) METHODS OF TREATMENT
AU8626801A (en) Method of forming complex
GB0013105D0 (en) Therapeutic compounds
AU2002366591A8 (en) Method of administering calcium citrate
GB0002762D0 (en) Method of treatment
GB0021476D0 (en) Method of attachment
GB0013928D0 (en) Methods of treatment